课题基金 / 基金详情

Hydroxychloroquine in systemic lupus

Hydroxychloroquine in systemic lupus
羟氯喹治疗系统性狼疮
批准号：
368030
负责人：
Bernatsky Sasha R
金额：
$24.94万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-09-01 至 2022-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=368030&lang=en
关键词：
Drug Effectiveness Drug Safety Epidemiology Rheumatic Diseases Systemic Lupus Erythematosis

项目摘要

项目成果

Bernatsky Sasha R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Systemic lupus (SLE) is a disease in which the immune system is over-active, causing inflammation in joints, skin, or any organ system. There are many areas where better approaches in SLE could improve outcomes. One example relates to hydroxychloroquine
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Environmental factors and risk of autoimmune rheumatic disease incidence and serology
Air pollution and systemic autoimmune rheumatic diseases
Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs
Drug safety and effectiveness in inflammatory musculoskeletal disease
海外基金